Polymorphism of methylenetetrahydrofolate reductase gene (C677T MTHFR) is not a confounding factor of the relationship between serum uric acid level and the prevalence of hypertension in Japanese men

Circulation Journal

Volumn 70, Issue 1, 2006, Pages 83-87

  Lwin, Htay ^a   Yokoyama, Tetsuji ^b   Yoshiike, Nobuo ^a   Saito, Kyoko ^b   Yamamoto, Akio ^c   Date, Chigusa ^d   Tanaka, Heizo ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c Hyogo Prefectural Institute of Public Health and Environmental Sciences   (Japan)

^d NARA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Blood pressure; C677T MTHFR; Hypertension prevalence; Japanese; Uric acid

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); URIC ACID;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; MUTATION; PREVALENCE; RANDOMIZATION; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ADULT; AGED; BLOOD PRESSURE; HUMANS; HYPERTENSION; JAPAN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; URIC ACID;

EID: 29644439699     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.83     Document Type: Article

References (37)

1. Myers AR, Epstein FH, Dodge HJ, Mikkelsen WM. The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med 1968; 45: 520-528.
2. Stamler J, Rhomberg P, Schoenberger JA, Shekelle RB, Dyer A, Shekelle S, et al. Multivariate analysis of the relationship of seven variables to blood pressure: Findings of the Chicago Heart Association Detection Project in Industry, 1967-1972. J Chronic Dis 1975; 28: 527-548.
3. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 2001; 19: 1209-1215.
4. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, et al. Serum uric acid and hypertension: The Olivetti heart study. J Hum Hypertens 1994; 8: 677-681.
5. Wannamethee SG. Serum uric acid is not an independent risk factor for coronary heart disease. Curr Hypertens Rep 2001; 3: 190-196.
6. Ueshima H, Shimamoto T, Iida M, Konishi M, Tanigaki M, Doi M, et al. Alcohol intake and hypertension among urban and rural Japanese populations. J Chronic Dis 1984; 37: 585-592.
7. Okada M, Ueda K, Omae T, Takeshita M, Hirota Y. The relationship of serum uric acid to hypertension and ischemic heart disease in Hisayama population, Japan. J Chronic Dis 1982; 35: 173-178.
8. Okada M, Takeshita M, Ueda K, Omae T, Hirota Y. Factors influencing the serum uric acid level: A study based on a population survey in Hisayama town, Kyushu, Japan. J Chronic Dis 1980; 33: 607-612.
9. Ramsay LE. Hyperuricaemia in hypertension: Role of alcohol. BMJ 1979; 1: 653-654.
10. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9.
11. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
12. Goyette P, Frosst P, Rosenblatt DS, Rozen R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am J Hum Genet 1995; 56: 1052-1059.
13. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eokfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
14. Lwin H, Yokoyama T, Date C, Yoshiike N, Kokubo Y, Tanaka H. Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetra- hydrofolate reductase gene (C677T MTHFR)? A cross-sectional study in a Japanese rural population. J Epidemiol 2002; 12: 126-135.
15. Perry IJ. Homocysteine, hypertension and stroke. J Hum Hypertens 1999; 13: 289-293.
16. Dalery K, Lussier-Cacan S, Selhub J, Davignon J, Latour Y, Genest J Jr. Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol 1995; 75: 1107-1111.
17. Wilcken DE, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol 1996; 16: 878-882.
18. Guillen M, Corella D, Portoles, Gonzalez JI, Mulet F, Saiz C. Prevalence of the methylenetetrahydrofolate reductase 677C >T mutation in the Mediterranean Spanish population: Association with cardiovascular risk factors. Eur J Epidemiol 2001; 17: 255-261.
19. Rodriguez-Esparragon F, Hernandez-Perera O, Rodriguez-Perez JC, Anabitarte A, Diaz-Cremades JM, Losada A, et al. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values. Clin Exp Hypertens 2003; 25: 209-220.
20. Inamoto N, Katsuya T, Kokubo Y, Mannami T, Asai T, Baba S, et al. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 2003; 34: 1628-1633.
21. Nishio H, Lee MJ, Fujii M, Kano K, Kayaba K, Shimada K, et al. A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn J Hum Genet 1996; 41: 247-251.
22. Garfunkel VA, Porto PI, Garcia SI, Dieuzeide G, Kirszner T, Plotquin Y, et al. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension. J Hum Hypertens 2003; 17: 361-364.
23. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation 1998; 98: 2520-2526.
24. Morita H, Saito Y, Ohashi N, Yoshikawa M, Katoh M, Ashida T, et al. Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction. Circ J 2005; 69: 475-480.
25. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928-933.
26. Nagai Y, Tasaki H, Miyamoto M, Nihei S, Kobayashi K, Yamashita K, et al. Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease. Circ J 2002; 66: 158-162.
27. Nihei S, Tasaki H, Yamashita K, Ozumi K, Morishita T, Tsutsui M, et al. Hyperhomocysteinemia is associated with human coronary atherosclerosis through the reduction of the ratio of endothelium-bound to basal extracellular superoxide dismutase. Circ J 2004; 68: 822-828.
28. Motti C, Gnasso A, Bernardini S, Massoud R, Pastore A, Rampa P, et al. Common mutation in methylenetetrahydrofolate reductase: Correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 1998; 139: 377-383.
29. Zuo M, Nishio H, Lee MJ, Maejima K, Mimura S, Sumino K. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J Hum Genet 2000; 45: 257-262.
30. Iwai N, Yoshiike N, Saitoh S, Nose T, Kushiro T, Tanaka H. Leisure-time physical activity and related lifestyle characteristics among middle-aged Japanese: Japan Lifestyle Monitoring Study Group. J Epidemiol 2000; 10: 226-233.
31. Saito K, Yokoyama T, Yoshiike N, Date C, Yamamoto A, Muramatsu M, et al. Do the ethanol metabolizing enzymes modify the relationship between alcohol consumption and blood pressure? J Hypertens 2003; 21: 1097-1105.
32. th rev edn. Tokyo: Printing Office of Ministry of Finance, 1982.
33. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 422: 43-52.
34. Yoshiike N, Nakayama T, Yokoyama T, Tanaka H, Labarthe DR. Quality control for blood pressure measurement in population studies: Shibata Children's Heart Study. J Clin Epidemiol 1997; 50: 1169-1173.
35. Zhan S, Gao Y, Yin X, Huang Y, Hu Y, Li L. A case-control study on the relationship between abnormal homocysteine metabolism and essential hypertension. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 194-197 (in Chinese).
36. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999; 19: 217-246.
37. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis 2000; 148: 131-139.